<DOC>
	<DOCNO>NCT02555267</DOCNO>
	<brief_summary>This study investigate impact comprehensive geriatric assessment use activity daily living ( ADL ) , instrumental activity daily living ( IADL ) , Charlson 's comorbidity index ( CCI ) survival toxicity Korean patient diffuse large B-cell lymphoma ( DLBCL ) treat R-CHOP .</brief_summary>
	<brief_title>Geriatric Assessments Elderly Diffuse Large B-cell Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<criteria>Patients newly diagnose CD20+ DLBCL 65 year old Scheduled receive RCHOP chemotherapy Informed consent Other histology CD20+ DLBCL Primary central nervous system DLBCL Patients diagnosis cancer ( basal squamous cell carcinoma skin , cervical carcinoma situ , well differentiate thyroid cancer [ papillary follicular thyroid cancer ] ) within 3 year study entry treatment cancer within 3 year entry Consent withdrawal</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>geriatric assessment</keyword>
	<keyword>diffuse large B-cell lymphoma</keyword>
	<keyword>activity daily live</keyword>
	<keyword>instrumental activity daily live</keyword>
	<keyword>Charlson 's comorbidity index</keyword>
</DOC>